282 related articles for article (PubMed ID: 32012328)
1. High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.
Vela V; Juskevicius D; Gerlach MM; Meyer P; Graber A; Cathomas G; Dirnhofer S; Tzankov A
Hematol Oncol; 2020 Aug; 38(3):284-292. PubMed ID: 32012328
[TBL] [Abstract][Full Text] [Related]
2. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.
Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507
[TBL] [Abstract][Full Text] [Related]
3. Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma.
Moody S; Escudero-Ibarz L; Wang M; Clipson A; Ochoa Ruiz E; Dunn-Walters D; Xue X; Zeng N; Robson A; Chuang SS; Cogliatti S; Liu H; Goodlad J; Ashton-Key M; Raderer M; Bi Y; Du MQ
J Pathol; 2017 Sep; 243(1):3-8. PubMed ID: 28682481
[TBL] [Abstract][Full Text] [Related]
4. Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas.
Johansson P; Klein-Hitpass L; Grabellus F; Arnold G; Klapper W; Pförtner R; Dührsen U; Eckstein A; Dürig J; Küppers R
Oncotarget; 2016 Sep; 7(38):62627-62639. PubMed ID: 27566587
[TBL] [Abstract][Full Text] [Related]
5. Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin.
Vela V; Juskevicius D; Dirnhofer S; Menter T; Tzankov A
Virchows Arch; 2022 Feb; 480(2):403-413. PubMed ID: 34494161
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of NF-κB signal pathway-related genes in ocular MALT lymphoma.
Liu F; Karube K; Kato H; Arita K; Yoshida N; Yamamoto K; Tsuzuki S; Kim W; Ko YH; Seto M
Int J Clin Exp Pathol; 2012; 5(5):436-41. PubMed ID: 22808296
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
[TBL] [Abstract][Full Text] [Related]
8. Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.
Hyeon J; Lee B; Shin SH; Yoo HY; Kim SJ; Kim WS; Park WY; Ko YH
Mod Pathol; 2018 Sep; 31(9):1418-1428. PubMed ID: 29765142
[TBL] [Abstract][Full Text] [Related]
9. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.
Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J
Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009
[TBL] [Abstract][Full Text] [Related]
11.
Jangam D; Sridhar K; Butzmann A; Samghabadi P; Plowey ED; Ohgami RS
Curr Eye Res; 2020 Dec; 45(12):1583-1589. PubMed ID: 32339039
[TBL] [Abstract][Full Text] [Related]
12. The genetic landscape of dural marginal zone lymphomas.
Ganapathi KA; Jobanputra V; Iwamoto F; Jain P; Chen J; Cascione L; Nahum O; Levy B; Xie Y; Khattar P; Hoehn D; Bertoni F; Murty VV; Pittaluga S; Jaffe ES; Alobeid B; Mansukhani MM; Bhagat G
Oncotarget; 2016 Jul; 7(28):43052-43061. PubMed ID: 27248180
[TBL] [Abstract][Full Text] [Related]
13. Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.
Charlotte F; Doghmi K; Cassoux N; Ye H; Du MQ; Kujas M; Lesot A; Mansour G; Lehoang P; Vignot N; Capron F; Leblond V
Virchows Arch; 2006 Apr; 448(4):506-16. PubMed ID: 16323006
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the genetic landscape of pulmonary lymphomas.
Vela V; Juskevicius D; Prince SS; Cathomas G; Dertinger S; Diebold J; Bubendorf L; Horcic M; Singer G; Zettl A; Dirnhofer S; Tzankov A; Menter T
Mod Pathol; 2021 Feb; 34(2):371-379. PubMed ID: 32855441
[TBL] [Abstract][Full Text] [Related]
15. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
[TBL] [Abstract][Full Text] [Related]
16. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.
Honma K; Tsuzuki S; Nakagawa M; Karnan S; Aizawa Y; Kim WS; Kim YD; Ko YH; Seto M
Genes Chromosomes Cancer; 2008 Jan; 47(1):1-7. PubMed ID: 17886247
[TBL] [Abstract][Full Text] [Related]
17. Morphologic features of 115 lymphomas of the orbit and ocular adnexa categorized according to the World Health Organization classification: are marginal zone lymphomas in the orbit mucosa-associated lymphoid tissue-type lymphomas?
Lagoo AS; Haggerty C; Kim Y; Hammons M; Neufeld K; Redher C; Woodward J; Klintworth GK
Arch Pathol Lab Med; 2008 Sep; 132(9):1405-16. PubMed ID: 18788851
[TBL] [Abstract][Full Text] [Related]
18. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
White WL; Ferry JA; Harris NL; Grove AS
Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
[TBL] [Abstract][Full Text] [Related]
19. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
[TBL] [Abstract][Full Text] [Related]
20. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
